Noveris Health Sciences Inc (MYCOF) Stock Price & News

All values in CAD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-40.14K	-	-	32.79K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-70.57K	5.04K	316.29K	669.62K
Operating expense	-110.70K	5.04K	316.29K	702.42K
Total operating expenses	-110.70K	5.04K	316.29K	702.42K
Operating income	110.70K	-5.04K	-316.29K	-702.42K
Other non operating income	85.53K	-417.63K	-1.32M	640.56K
EBT including unusual items	73.79K	3.16M	-1.62M	22.81K
EBT excluding unusual items	73.79K	-405.27K	-1.62M	-155.29K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	73.79K	3.16M	-1.62M	22.81K
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-26.16K	-12.63K	-9.90K
Net interest expenses	-	-26.16K	-12.63K	-9.90K
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance